BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 164 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $959,000 | +4.2% | 8,950 | -0.0% | 0.02% | +4.2% |
| Q3 2021 | $920,000 | +31.6% | 8,951 | +12.6% | 0.02% | +14.3% |
| Q2 2021 | $699,000 | +421.6% | 7,950 | +448.3% | 0.02% | +250.0% |
| Q3 2020 | $134,000 | -79.4% | 1,450 | -82.1% | 0.01% | -76.0% |
| Q4 2019 | $649,000 | +1375.0% | 8,100 | +1250.0% | 0.02% | +1150.0% |
| Q3 2019 | $44,000 | -93.9% | 600 | -93.5% | 0.00% | -95.2% |
| Q3 2018 | $716,000 | +215.4% | 9,172 | +156.3% | 0.04% | +200.0% |
| Q2 2018 | $227,000 | +404.4% | 3,579 | +496.5% | 0.01% | +250.0% |
| Q4 2017 | $45,000 | +275.0% | 600 | +155.3% | 0.00% | +300.0% |
| Q2 2017 | $12,000 | – | 235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |